Harvard Clinical Endocrinology 2026

Clinical Endocrinology 2026 – Course Schedule (Harvard / MGH)

1. Overview

The Harvard Clinical Endocrinology 2026 course provides a comprehensive and evidence-based update on the diagnosis, evaluation, and management of complex endocrine disorders. The program features expert-led sessions and case-based discussions spanning multiple subspecialties, including pituitary conditions, calcium and bone disorders, diabetes and metabolism, reproductive endocrinology, and thyroid diseases.

Course Date: March 21-25, 2026

Clinical Strategies and Comprehensive Updates for State-of-the-Art Endocrine Care

Clinical Endocrinology 2026 is a live online course, using live streaming, electronic Q&A, and other remote learning technologies. 

For more than 50 years, the endocrinology faculty from Harvard Medical School and Massachusetts General Hospital have offered the course Clinical Endocrinology—the acclaimed annual update of current endocrine diagnostic and management strategies. If you provide care to patients with endocrine disorders, this course will be invaluable to your medical decision-making and patient care.

Education to Optimize Care of Patients with Endocrine Disorders
You can rely on this program to enhance your endocrine knowledge and optimize your care of endocrine disorders with evidence-based strategies. This course provides:

• Improved screening for common conditions
• The newest clinical guidelines, including the new guidelines for primary hyperparathyroidism and hypoparathyroidism
• Expanded options for diagnosis
• State-of-the-art treatment strategies
• Guidance for challenging cases
• Updates for management of common and rare endocrine disorders
• New concepts in endocrinology and diabetes
• Pediatric endocrinology updates
• Skills advancement workshops, including thyroid ultrasound, insulin pump management, and continuous glucose monitoring (CGM)
• Dedicated time to pose your specific questions to experts

A Practical, Comprehensive Update for Busy Clinicians
This program delivers comprehensive updates to improve screening, evaluation, diagnosis, and treatment of:

• Pituitary lesions
• Pituitary hormone excess and hypopituitarism
• Diabetes: type 1, type 2, and in pregnancy
• Obesity and metabolic disorders
• Lipid disorders
• Calcium/bone disorders, including osteoporosis
• Thyroid nodules, cancer, hyper- and hypothyroidism
• Adrenal conditions and incidentalomas
• Male and female reproductive conditions

Our faculty, world renowned for their clinical, research, and teaching achievements, cover important updates and recent advances for a broad array of endocrine conditions:

• Acromegaly
• Adrenal incidentaloma
• Adult growth hormone deficiency
• Cushing’s disease
• Diabetes in pregnancy
• Diabetes type 1
• Diabetes type 2
• Erectile dysfunction
• Gestational diabetes
• Glucocorticoid-induced osteoporosis
• Graves’ eye disease
• Hyper- and hypoparathyroidism
• Hyper- and hypothyroidism
• Hyperprolactinemia
• Hypo- and hypercalcemia
• Hypoglycemia
• Hypopituitarism
• Insulin pumps, continuous glucose monitoring (CGM), and technology management in type 1 DM
• Lipid disorders
• Male and female hypogonadism
• Menopause
• Obesity and metabolic disorders
• Osteoporosis
• Pheochromocytoma
• Pituitary surgery and radiation
• Polycystic ovarian syndrome / hyperandrogenism
• Primary aldosteronism
• Sellar region abnormalities
• Thyroid cancer
• Thyroid disease and pregnancy
• Thyroid nodules
• Thyroid ultrasound
• Transgender care

Answers to Frequently Asked Clinical Questions
This course provides answers to frequently encountered questions across the spectrum of endocrinology, including:

• How do I decipher diabetes devices?
• How should I choose between the new medications for acromegaly and Cushing’s?
• When a pituitary lesion is found incidentally, what could the diagnosis be, and what diagnostic tests should I order?
• Do I need to treat a low TSH if the free T4 and T3 is normal and the patient feels fine?
• Is there a new goal for TSH during pregnancy?
• When should I repeat a screening bone density test?
• When should I start and end an osteoporosis drug “holiday”?What is your approach to obesity-related / functional hypogonadism?
• Is there a role for using SERMs (e.g., clomiphene) instead of Testosterone Replacement Therapy (TRT) in hypogonadal men?
• How do you monitor hematocrit and manage polycythemia on TRT?
• What comorbidities should I screen for with PCOS?
• How can I distinguish PCOS from hypothalamic amenorrhea in an athlete?
• What is the difference between hormone replacement therapy and menopausal hormone therapy?
• How can I tell if a patient with “spells” has a pheochromocytoma?
• In a patient with an adrenal incidentaloma, what are the right tests to screen for hormone excess and when should I worry about adrenal cancer?

2. Learning Objectives

• Evaluate and manage complex pituitary and adrenal disorders, including hypopituitarism, Cushing’s syndrome, acromegaly, and adrenal incidentalomas.

• Implement modern diagnostic and therapeutic strategies for diabetes, utilizing newer medications, advanced diabetes technology, and specialized inpatient management protocols.

• Assess and treat calcium and bone disorders, focusing on hyperparathyroidism, hypercalcemia, and targeted therapies for osteoporosis.

• Formulate evidence-based management plans for thyroid conditions, including practical updates on thyroid ultrasound, nodules, hyperthyroidism, and thyroid cancer.

• Apply current paradigms in reproductive endocrinology, addressing male hypogonadism, amenorrhea, and gender-affirming hormonal treatments.

3. Target Audience

• Who Should Participate
• Endocrinologists
• Internists
• Family Physicians
• Pediatricians
• Geriatricians
• Nurse Practitioners
• Physician Assistants

4. Topics

1. 01 Hypopituitarism A Comprehensive Update

2. 02 Cushing’s Diagnosis and Treatment in 2026

3. 03 Hyperprolactinemia and Prolactinomas

4. 04 What Is the Sellar Lesion Illustrative Pituitary Cases

5. 05 Expert Faculty Panel for Q & A

6. 06 Current Diagnosis and Management of Adult Growth Hormone Deficiency

7. 07 Clinical Management of Acromegaly

8. 08 Pituitary Case Discussion

9. 09 Expert Faculty Panel for Q & A

10. 10 Primary Hyperparathyroidism 2026 A Comprehensive Update

11. 11 Hypo- and Hypercalcemia Case-Based Diagnosis and Mechanisms

12. 12 Expert Panel Q & A

13. 13 Therapeutic Advances in Rare Bone Diseases

14. 14 Phosphate in Practice Clinical Insights for Endocrinologists

15. 15 Bones, Groans, and Stones Mineral Metabolism Clinical Cases

16. 16 Osteoporosis Current Diagnostic Approaches

17. 17 Osteoporosis Treatment Strategies in 2026

18. 18 Optimal Long-term Management of Established OP Sequential and Alternate

19. 19 State-of-the-Art Management of Glucocorticoid-Induced Osteoporosis

20. 20 Osteoporosis Panel Ask the Experts

21. 21 Calcium & Bone Disorders Mineral MetabolismCalcium Cases

22. 22 Diabetes & Metabolic Disorders Challenging Diabetes Cases

23. 23 Pituitary Pediatric endocrinology for adult endocrinologists

24. 24 Reproductive Topics in male reproduction A case-based approach

25. 25 Thyroid Lessons learned from challenging thyroid cases

26. 26 Modern-Day Therapy and Results of Treatment of Type 1 Diabetes

27. 27 Update in Diabetes Technology

28. 28 Diabetes Subtypes and Diabetes Clinical Genetics

29. 29 What’s New with Old Diabetes Medications

30. 30 Newer Diabetes Medications, New Indications

31. 31 Overcoming Barriers in Type 2 Diabetes Management

32. 32 Pulling It All Together Ask the Diabetes Experts

33. 33 Obesity Medicine

34. 34 State-of-the-Art Lipid Management

35. 35 Inpatient Diabetes Management Evidence and Strategies

36. 36 Diabetes in Pregnancy

37. 37 Gestational Diabetes Melitus

38. 38 Pulling It All Together Ask the Diabetes Experts

39. 39 Calcium & Bone Disorders Cases Topics on osteoporotic fracture secondary prevention

40. 40 Diabetes & Metabolic Disorders Challenges in Cystic Fibrosis-Related Diabetes The Emerging Role of Diabetes Technology beyond Type 1 Diabetes

41. 41 Pituitary Updates in Diagnosis & Treatments of Adrenal Insufficiency

42. 42 Reproductive Endocrinology Rapid Fire Review

43. 43 Thyroid Illustrative cases of thyroid dysfunction

44. 44 Endocrine Hypertension Case-Based Update on Pheochromocytoma and Primary Aldosteronism

45. 45 Adrenal Incidentaloma Illustrative Cases of Current Diagnostic Strategies

46. 46 Approach to the Menopausal Patient in 2026

47. 47 Current Diagnosis and Management of Amenorrhea and Hyperandrogenism

48. 48 Reproductive Faculty Panel for Audience Q & A

49. 49 Male Hypogonadism Insights into Pathophysiology and Evaluation

50. 50 Optimizing Treatment Strategies and Patient Outcomes for Male Hypogonadism

51. 51 Gender-Affirming Hormonal Treatment of Transgender Individuals Changing Paradigms in a Changing Society

52. 52 Erectile Dysfunction A Urologist’s Perspective

53. 53 Expert Reproductive Faculty Answer Your Questions

54. 54 Calcium & Bone Disorders Calcium and bone disorder cases in children and young adults

55. 55 Diabetes & Metabolic Disorders Hypoglycemia

56. 56 Pituitary Integrated Surgical and Endocrine DecisionMaking in Pituitary Tumors

57. 57 Reproductive Topics in Reproduction and Congenital Adrenal Hyperplasia A Case-Based Approach

58. 58 Thyroid Practical update on thyroid ultrasound

59. 59 Subclinical Thyroid Disease Do Endocrinologists Pay Attention to the Evidence

60. 60 The 2026 Approach to Hyperthyroidism

61. 61 Graves’ Eye Disease

62. 62 Thyroid Nodules A Costly Problem

63. 63 Expert Thyroid Panel Answers Your Questions

64. 64 Hypothyroidism A Case-Based Review

65. 65 Thyroid Cancer State of the Art in 2026

66. 66 Thyroid Disease in Pregnancy A Comprehensive Update

67. 67 Panel of Thyroid Specialists for Q & A

68. Day 1 Pituitary FULL DAY

69. Day 2 Calcium and Bone Disorders FULL DAY

70. Day 3 Diabetes and Metabolic Disorders FULL DAY

71. Day 4 Reproductive and Adrenal FULL DAY RECORDING

72. Day 5 Thyroid FULL DAY RECORDING